Država: Irska
Jezik: angleščina
Source: HPRA (Health Products Regulatory Authority)
FLUORESCEIN SODIUM
Chauvin Pharmaceuticals Limited
FLUORESCEIN SODIUM
2.0 %w/v
Eye Drops Solution
Product not subject to medical prescription
Authorised
0000-00-00
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Minims Fluorescein Sodium 2%, w/v Eye Drops, Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 2% w/v solution of Fluorescein Sodium _For a full list of excipients, see section 6.1_ 3 PHARMACEUTICAL FORM Eye Drops, solution (Eye Drops) Clear, orange-red, aqueous single-use eye drop solution 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS As a diagnostic stain. Fluorescein does not stain a normal cornea but conjunctival abrasions are stained yellow or orange, corneal abrasions or ulcers are stained a bright green and foreign bodies are surrounded by a green ring. Fluorescein can be used in diagnostic examinations including Goldmann tonometry and in the fitting of hard contact lenses. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Adults, Children and the Elderly Instil dropwise into the eye. Sufficient solution should be applied to stain the damaged areas. Excess may be washed away with sterile saline solution. 4.3 CONTRAINDICATIONS Use in patients with a known hypersensitivity to Fluorescein. Not to be used with soft contact lenses. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Special care should be taken to avoid microbial contamination. Each Minims unit should be discarded after a single use. 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION None known. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 15/08/2013_ _CRN 2117482_ _page number: 1_ 4.6 FERTILITY, PREGNANCY AND LACTATION Safety for use in pregnancy and lactation has not been established, therefore use only when considered essential by the physician. 4.7 EFFECTS ON ABILITY TO DRIVE AND USE MACHINES May cause transient blurring of vision on i Preberite celoten dokument